Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2002
11/07/2002WO2002088319A2 Mini-adenoviral vector and methods of using same
11/07/2002WO2002088318A2 Lipid-comprising drug delivery complexes and methods for their production
11/07/2002WO2002088316A2 G-protein coupled receptors
11/07/2002WO2002088314A2 Ovary-specific genes and proteins
11/07/2002WO2002088313A2 Novel human nuclear transporters and polynucleotides encoding the same
11/07/2002WO2002088312A2 Isolated human secreted proteins, nucleic acid molecules encoding human secreted proteins, and uses thereof
11/07/2002WO2002088310A2 Cobra gene and uses thereof
11/07/2002WO2002088309A2 Fusion genes associated with acute megakaryoblastic leukemias
11/07/2002WO2002088305A2 Isolation and identification of mouse and human transcription control elements associated with cytochrome expression
11/07/2002WO2002088304A2 Compositions and methods for suppressing immune responses
11/07/2002WO2002088302A2 Method for secreting proteins by bacteria, leader sequences and vectors for carrying out said method
11/07/2002WO2002088184A1 A molecular marker
11/07/2002WO2002088183A2 G-protein coupled receptor
11/07/2002WO2002088182A1 Nove g protein-coupled receptor protein and dna thereof
11/07/2002WO2002088180A2 Use of alpha 1-antichymotrypsin for the manufacture of a composition for treatment, prevention or diagnosis of poorly healing diabetic or arterial wounds
11/07/2002WO2002088179A1 Protein participating in restoration from cytoplasmic male sterility to fertility and gene encoding the same
11/07/2002WO2002088178A2 Antigens of group b streptococcus and corresponding dna fragments
11/07/2002WO2002088177A1 Erav diagnostics and vaccines
11/07/2002WO2002088176A2 Genes and proteins for the biosynthesis of polyketides
11/07/2002WO2002088175A1 Crohn's disease antibody-binding peptide and method of examining crohn's disease
11/07/2002WO2002088173A2 Viral-mediated delivery and in vivo expression of polynucleotides encoding anti-angiogenic proteins
11/07/2002WO2002088171A2 Combinatorial libraries of monomer domains
11/07/2002WO2002088168A2 Codon-optimised nucleic acid coding for apoaequorin and uses thereof
11/07/2002WO2002088164A1 Human ox2 receptors
11/07/2002WO2002088161A1 Method for expression of human interferon alpha 1 in pichia pa storis
11/07/2002WO2002088081A2 Wnt and frizzled receptors as targets for immunotherapy in head and neck squamous cell carcinomas
11/07/2002WO2002087631A1 Gastrin-receptor-avid peptide conjugates
11/07/2002WO2002087613A1 Recombinant mhc molecules useful for manipulation of antigen-specific t-cells
11/07/2002WO2002087606A2 Modulators of the hypocretin system and methods of screening therefor
11/07/2002WO2002087594A1 Non-viral vesicle vector for cardiac specific gene delivery
11/07/2002WO2002087540A1 Artificial blood made of hemoglobin encapsulated in liposomes
11/07/2002WO2002087510A2 Subcellular targeting of therapeutic proteins
11/07/2002WO2002087509A2 Colloidal metal compositions and methods
11/07/2002WO2002087507A2 Breast cancer-associated genes and uses thereof
11/07/2002WO2002087505A2 3-structure of a whole integrin $g(a)v$g(b)3 extracellular region and uses therefor
11/07/2002WO2002087503A2 Compositions and methods for treating colorectal polyps and cancer
11/07/2002WO2002087419A2 Biological pacemaker
11/07/2002WO2002087417A2 Alleviation of the memory deficits and memory components of psychiatric dysfunctions by altering atypical pkm activity
11/07/2002WO2002087306A2 High throughput cell-based assay for monitoring sodium channel activity and discovery of salty taste modulating compounds
11/07/2002WO2002087304A2 Il2 peptides; peptides and peptide dimers both derived from interleukin-2
11/07/2002WO2002074980A3 Muteins of hypoxia inducible factor alpha and methods of use thereof
11/07/2002WO2002068614A3 Interferon regulatory factor-1/human estrogen receptor fusion protein and its use for treating carcinomas
11/07/2002WO2002068588A3 Cytokine receptor common gamma chain like
11/07/2002WO2002067857A3 Modified annexin proteins and methods for preventing thrombosis
11/07/2002WO2002066605A3 Compositions and methods relating to breast specific genes and proteins
11/07/2002WO2002066503A3 H. influenzae antigen basb213
11/07/2002WO2002057420A3 50 human secreted proteins
11/07/2002WO2002053589A3 Nucleic acid molecules encoding dim interactors and uses therefor
11/07/2002WO2002048378A3 Enhancement of freezing tolerance in transgenic plants
11/07/2002WO2002044348A3 Method for purifying adenoviruses
11/07/2002WO2002040649A8 Slo2 and slo4, novel potassium channel proteins from human brain
11/07/2002WO2002040513A3 Nucleic acid vaccine comprising a fusion protein including an adjuvant sequence from a plant viral coat protein
11/07/2002WO2002038594A9 Novel therapeutic compositions for treating infection by lawsonia spp
11/07/2002WO2002038586A3 Haplotypes of the il6 gene
11/07/2002WO2002036747A3 Peripheral nerve type sodium channels
11/07/2002WO2002032938A3 Regulation of human pgc-1-like protein
11/07/2002WO2002030972A3 Regulation of nf-at interacting protein nip 45 like protein
11/07/2002WO2002030971A3 Basb205 polypeptides and polynucleotides coding therefor
11/07/2002WO2002030967A3 Novel compounds
11/07/2002WO2002030960A3 Polypeptide from haemophilus influenza
11/07/2002WO2002029064A3 Method for establishing germ cell-specific gene expression
11/07/2002WO2002028897A3 Human g-protein coupled receptor and uses thereof
11/07/2002WO2002026823A3 A novel human g-protein coupled receptor, hgprbmy7, expressed highly in spinal cord
11/07/2002WO2002024927A3 Regulation of human adam-ts 1 precursor-like protein
11/07/2002WO2002024728A3 Mammalian nuclear receptor cofactor cf6 and methods of use
11/07/2002WO2002020753A3 Human gaba transporter protein and polynucleotides encoding the same
11/07/2002WO2002020565A3 Collections of repeat proteins comprising repeat modules
11/07/2002WO2002016561A3 Mfq-111, a novel human gtpase like protein
11/07/2002WO2002016414A3 Composition for the elimination of autoreactive b-cells
11/07/2002WO2002002600A3 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF
11/07/2002WO2001092300A3 Chimeric gfp-aequorin as bioluminescent ca++ reporters at the single cell level
11/07/2002WO2001085768A9 G-protein coupled receptors and uses therefor
11/07/2002WO2001057186A9 Methods and compositions for diagnosis and treatment of cancer based on esf
11/07/2002WO2001057086A9 Novel human g protein coupled receptor proteins and polynucleotides encoding the same
11/07/2002WO2001046408A9 Molecular clones with mutated hiv gag/pol, siv gag and siv env genes
11/07/2002WO2001046406A9 New qtl's on chromosomes x, 2, 6 and 7 of pigs
11/07/2002WO2001045493A3 Transcription factor stress-related proteins and methods of use in plants
11/07/2002WO2001038492A9 Improved inoculant strains of bradyrhizobium japonicum
11/07/2002WO2001037881A9 Gene therapy of hiv-positive patients by the expression of membrane-anchored gp41 peptides
11/07/2002WO2001027079A9 Compositions and methods of use of ligands that bind components of the blood coagulation/clotting pathway for the treatment of cancer and angiogenic-based disease
11/07/2002WO2001026676A9 Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (mpif-1)
11/07/2002WO2001018020A9 A eukaryotic mechanosensory transduction channel
11/07/2002WO2001000677A9 A method of modulating integrin mediated cellular activity and agents useful for same
11/07/2002US20020166146 Maize PR1 polynucleotides and methods of use
11/07/2002US20020166143 Nucleotide sequences coding plypeptide for use in the generation of disease resistant plants
11/07/2002US20020166142 Pathogen-resistant plants and method for production thereof
11/07/2002US20020166141 Antimicrobial peptides and methods of use
11/07/2002US20020166139 Methods for enhancing a plant stress response
11/07/2002US20020166136 Anti-inflammatory therapies using cytokine signaling regulated by a SOCS-3 promoter
11/07/2002US20020166135 Modulation of preferential aspects of nervous system; obtain human, administer modulator, monitor expression of preferential neuropeptides in brain
11/07/2002US20020166134 Cardiomyocytes with enhanced proliferative potenial, and methods for preparing and using same
11/07/2002US20020166133 Neokine protein and nucleic acid molecules and uses therefor
11/07/2002US20020166131 Nucleotide sequences coding polypeptide for use in the treatment of disease parkinson's, irritable bowel syndrome and cardiovascular disorders
11/07/2002US20020165384 Steroid hormone receptor polynucleotides, polypeptides, and antibodies
11/07/2002US20020165383 Tenebrio antifreeze proteins
11/07/2002US20020165382 Transcription factors that regulate normal and malignant cell growth
11/07/2002US20020165380 A nucleic acid probe consisting a nucleic acid molecule of at least 15 nucleotides which is complementary to the antisense sequence of a unique fragment of the sequence of a nucleic acid molecule encoding a mammalian fb41 receptor
11/07/2002US20020165379 An isolated nucleic acid encoding a monomer of a calcium-activated potassium channel, and the monomer having molecular weight 40-80 kDa, unit conductance 2-6-pS, binding to antibodies generated against specific peptide sequence
11/07/2002US20020165378 Human membrane antigen tm4 superfamily protein and dna encoding this protein
11/07/2002US20020165375 Parasitic helminth cuticlin proteins and uses thereof
1 ... 1722 1723 1724 1725 1726 1727 1728 1729 1730 1731 1732 1733 1734 1735 1736 1737 1738 1739 1740 1741 1742 ... 2916